1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10
Gullo, G., Kennedy, J., Breathnach, O., McCaffrey, J., Keane, M., Martin, M., Gupta, R., Leonard, G., Calvert, P., Donnellan, P., Walshe, J., Mc Dermott, E., Cairney, S., Bose, R., Scott, K., HernandoVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)30912-1
Date:
September, 2015
File:
PDF, 59 KB
english, 2015